Molecular events in allergic inflammation: experimental models and possible modulation

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Allergic inflammation involves a complex molecular network including cytokines, kinins, and adhesion molecules.
• Intercellular Adhesion Molecule 1 (ICAM-1) is a key adhesion molecule crucial for inflammatory cell recruitment and locomotion in allergic responses.

Purpose of the Study:

• To investigate the role and modulation of ICAM-1 in allergic inflammation using experimental eye and nose models.
• To evaluate the in vivo antiallergic properties of various compounds by assessing their impact on inflammatory infiltration and ICAM-1 expression.

Main Methods:

• Utilized conjunctival and nasal epithelium experimental models for studying allergic inflammation.
• Employed natural allergen exposure and specific/aspecific provocation tests.
• Assessed the effects of compounds on inflammatory cell infiltration and ICAM-1 expression on epithelia.

Main Results:

• Demonstrated that new antihistamines, deflazacort, and local nasal immunotherapy can reduce inflammatory infiltration.
• Showed that these treatments also decrease ICAM-1 expression on epithelia.
• Highlighted the effectiveness of eye and nose models in evaluating antiallergic compound efficacy.

Conclusions:

• Pharmacological modulation of adhesion molecules, particularly ICAM-1, represents a promising therapeutic strategy for allergic inflammation.
• Nasal and conjunctival challenge models are well-tolerated and effective for in vivo investigation of antiallergic treatments.
• Targeting ICAM-1 offers a potential avenue for developing novel treatments for allergic diseases.